Skip to main content
Log in

D2 dopamine receptor (DRD2) gene Taq1A polymorphism and the eatingrelated psychological traits in eating disorders (anorexia nervosa and bulimia) and obesity

  • Original Research Paper
  • Published:
Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity Aims and scope Submit manuscript

Abstract

OBJECTIVE: Food is considered a reinforcing agent, like a variety of substances such as alcohol and other drugs of abuse that produce pleasure. Psychopathological traits related to food intake are demonstrated in eating disorders as in obesity with different genetic aspects for these diseases. Recently, the prevalence of TaqA1 allele has been associated to alcohol, drug abuse and carbohydrate preference. For this reason, the aim of this study was to evaluate if the presence of A1 allele, in eating disorders and obesity, is associated with some particular psycho-pathological characteristics. METHODS: We studied the presence of TaqA1 in Italian subjects affected by obesity (n=71), anorexia (n=28), bulimia (n=20) and in control group (n=54). The Eating Disorders Inventory (EDI test) was used to evaluate the psychological profiles. Patients without alcohol and drugs abuse were selected (>125 ml/day). RESULTS: The A1+ allele, both in A1/A1 and A1/A2 genotypes, was not differently distributed among disease groups; on the contrary two EDI subscales (Drive for thinness and Ineffectiveness) resulted associated with A1+ allele without effect of the eating disease or obesity. CONCLUSION: These results confirm that the presence of A1+ allele is not simply related to body weight but the A1+ allele might be a marker of a genetic psychological condition in people with high risk to develop pathological eating behaviour.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Hinney A., Remschmidt H., Hebebrand J.: Candidate gene polymorphisms in eating disorders. Eur. J. Pharmacol., 410, 147–159, 2000.

    Article  PubMed  CAS  Google Scholar 

  2. Klump K.L., Kaye W.H., Strober M.: The evolving genetic foundation of eating disorders. Psychiatr. Clin. North Am., 24, 215–225, 2001.

    Article  PubMed  CAS  Google Scholar 

  3. Bergen A.W., Yeager M., Welch R., Ganjei J.K., Deep-Soboslay A., Haque K., van der Bree M.B.M., Goldman D., Berrettini W.H., Kaye W.H.: Price Foundation Collaborative Group: Candidate gene analysis of the Price Foundation Anorexia nervosa affected relative pair dataset. Current drug targets. CNS neurological disorders, 2, 41–51, 2003.

    Article  PubMed  CAS  Google Scholar 

  4. Snyder E.E., Walts B., Pérusse L., Chagnon Y.C., Weisnagel S.J., Rankinen T., Bouchard C.: The human Obesity Gene Map: the 2003 update. Obes. Res., 12, 369–439, 2004.

    Article  PubMed  CAS  Google Scholar 

  5. Gorwood P., Kipman A., Foulon C.: The human genetics of anorexia nervosa. Eur. J. Pharmacol., 480, 163–170, 2003.

    Article  PubMed  CAS  Google Scholar 

  6. Kaye W.H., Devlin B., Barbarich N., Bulik C.M., Thornton L., Bacanu S.A., Fichter M.M., Halmi K.A., Kaplan A.S., Strober M., Woodside D.B., Bergen A.W., Crow S., Mitchell J., Rotondo A., Mauri M., Cassano G., Keel P., Plotnicov K., Pollice C., Klump K.L., Lilenfeld L.R., Ganjei J.K., Quadflieg N., Berettini W.H.: Genetic analysis of bulimia nervosa: methods and sample description. Int. J. Eat. Disord., 35, 556–570, 2004.

    Article  PubMed  Google Scholar 

  7. Kowalski T.J.: The future of genetic research on appetite behaviour. Appetite, 42, 11–14, 2004.

    Article  PubMed  Google Scholar 

  8. Bruins-Slot L., Gorwood P., Bouvard M., Blot P., Ades J., Feingold J., Schwartz J.C., Mouren-Simeoni M.C.: Lack of association between anorexia nervosa and D3 dopamine receptor gene. Biol. Psychiatry, 43, 76–78, 1998.

    Article  PubMed  CAS  Google Scholar 

  9. Hinney A., Schneider J., Ziegler A., Lehmkuhl G., Poustka F., Schmidt M.H., Mayer H., Siegfried W., Remschmidt H., Hebebrand J.: No evidence for involvement of polymorphisms of the dopamine D4 receptor gene in anorexia nervosa, underweight, and obesity. Am. J. Med. Genet., 88, 594–597, 1999.

    Article  PubMed  CAS  Google Scholar 

  10. Shinohara M., Mizushima H., Hirano M., Shioe K., Nakazawa M., Yoshimitsu H., Yutaka O., Shigenobu K.: Eating disorders with binge-eating behaviour are associated with the s allele of the 3′-UTR VNTR polymorphism of the dopamine transporter gene. J. Psychiatr. Neurosci., 29, 134–137, 2004.

    Google Scholar 

  11. Bergen A.W., Yeager M., Welch R.A., Haque K., Ganjei J.K., van der Bree M.B., Mazzanti C., Nardi I., Fichter M.M., Halmi K.A., Kaplan A.S., Strober M., Treasure J., Woodside D.B., Bulik C.M., Bacanu S.A., Devlin B., Berrettini W.H., Goldman D., Kaye W.H.: Association of multiple DRD2 polymorphisms with anorexia nervosa. Neuropsychopharmacology, 30, 1703–1710, 2005.

    Article  PubMed  CAS  Google Scholar 

  12. Thompson J., Thomas N., Singleton A., Piggott M., Lloyd S., Perry E.K., Morris C.M., Perry R.H., Ferrier I.N., Court J.A.: D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. Pharmacogenetics, 7, 479–484, 1997.

    Article  PubMed  CAS  Google Scholar 

  13. Thomas G.N., Critchley J.H., Tomlinson B., Cockram C.S., Chan J.C.N.: Relationships between the TaqI polymorphism of the dopamine D2 receptor and blood pressure in hyperglycaemic and normoglycaemic Chinese subjects. Clin. Endocrinol., 55, 605–611, 2001.

    Article  CAS  Google Scholar 

  14. Comings D.E., Gade R., MacMurray J.P., Muhleman D., Peters W.R.: Genetic variants of the human obesity (OB) gene: association with body mass index in young women, psychiatric symptoms and interaction with the dopamine D2 receptor (DRD2) gene. Mol. Psychiatry, 1, 325–335, 1996.

    PubMed  CAS  Google Scholar 

  15. Comings D.E., Flanagan S.D., Dietz G., Muhleman D., Knell E., Gysin R.: The dopamine D2 receptor (DRD2) as a major gene in obesity and height. Biochemical Medicine and Metabolic Biology, 50, 176–185, 1993.

    Article  PubMed  CAS  Google Scholar 

  16. Noble E.P., Noble R.E., Ritchie T., Syndulko K., Bohlman M.C., Noble L.A., Zhang Y., Sparkes R.S., Grandy D.K.: D2 dopamine receptor gene and obesity. Int. J. Eat. Disord., 15, 205–217, 1994.

    Article  PubMed  CAS  Google Scholar 

  17. Blum K., Sheridan P.J., Wood R.C., Braverman E.R., Chen T.J., Cull J.C., Comings D.E.: The D2 dopamine receptor gene as a determinant of reward deficiency syndrome. J. Roy. Soc. Med., 89, 396–400, 1996.

    PubMed  CAS  Google Scholar 

  18. Noble E.P.: D2 dopamine receptor gene in psychiatric and neurologic disorders and its phenotypes. Am. J. Med. Gen., 116B, 103–125, 2003.

    Article  Google Scholar 

  19. Conner B.T., Noble EP., Berman S.M., Ozkaragoz T., Ritchie T., Antolin T., Sheen C.: DRD2 genotypes and substance use in adolescent children of alcoholics. Drug Alcohol Dependence, 79, 379–387, 2005.

    Article  PubMed  CAS  Google Scholar 

  20. Neville M.J., Johnstone E.C., Walton R.T.: Identification and characterization of ANKK1: a novel kinase gene closely linked to DRD2 on chromosome band 11q23.1. Hum. Mutat., 23, 540–545, 2004.

    Article  PubMed  CAS  Google Scholar 

  21. Garner D.M., Olmstead M.P., Polivy J.: Development and validation of a multidimensional eating disorders inventory for anorexia-nervosa and bulimia. Int. J. Eat. Disord., 2, 15–34, 1983.

    Article  Google Scholar 

  22. Rizzardi M., Trombini E., Trombini G., Gadner D.M.: EDI-2 adattamento italiano. Firenze, O.S., 1995.

    Google Scholar 

  23. Hinney A., Schneider J., Ziegler A., Lehmkuhl G., Poustka F., Schmidt M.H., Mayer H., Siegfried W., Remschmidt H., Hebebrand J.: No evidence for involvement of polymorphisms of the dopamine D4 receptor gene in anorexia nervosa, underweight and obesity. Am. J. Med. Genetics, 88, 594–597, 1999.

    Article  CAS  Google Scholar 

  24. Jenkinson C.P., Hanson R., Cray K., Wiedrich C., Knowler W.C., Bogardus C., Baier L.: Association of dopamine D2 receptor polymorphisms Ser311Cys and Taq1A with obesity or type 2 diabetes mellitus in Pima Indians. Int. J. Obes., 24, 1233–1238, 2000.

    Article  CAS  Google Scholar 

  25. Southon A., Walder K., Sanigorski A.M., Zimmet P., Nicholson G.C., Kotowicz M.A., Collier G.: The Taq1A and Ser311Cys polymorphisms in the dopamine D2 receptor gene and obesity. Diab. Nutr. Metab., 16, 72–76, 2003.

    CAS  Google Scholar 

  26. Young R.McD., Lawford B.R., Feeney G.F.X., Ritchie T., Noble EP.: Alcohol-related expectancies are associated with the D2 dopamine receptor and GABAA receptor β3 subunit genes. Psychiatry Res., 127, 171–183, 2004.

    Article  PubMed  CAS  Google Scholar 

  27. Connor J.P., Young R.McD., Lawford B.R., Ritchie T.L., Noble E.P.: D2 dopamine receptor polymorphism is associated with severity of alcohol dependence. Eur. Psychiatry, 17, 17–23, 2002.

    Article  PubMed  CAS  Google Scholar 

  28. Van der Stelt M., Di Marzo V.: The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: implications for neurological and psychiatric disorders. Eur. J. Pharmacol., 480, 133–150, 2003.

    Article  PubMed  Google Scholar 

  29. Pohjalainen T., Rinne J.O., Naguen K., Lehikoinen P., Antila K., Syvalahti E.K., Hietela J.: The A1 allele of the human dopamine D2 receptor gene predicts low D2 receptor availability in healthy volunteers. Mol. Psychiatry, 3, 256–360, 1998.

    Article  PubMed  CAS  Google Scholar 

  30. Volkow N.D., Fowler J.S.: Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex. Cerebral Cortex, 10, 318–325, 2000.

    Article  PubMed  CAS  Google Scholar 

  31. Epstein L.H., Wright S.M., Paluch R.A., Leddy J.J., Hawk L.W. Jr,, Jaroni J.L., Saad F.G., Crystal-Mansour S., Shields P.G., Lerman C.: Relation between food reinforcement and dopamine genotypes and its effect on food intake in smokers. Am. J. Clin. Nutr., 80, 82–88, 2004.

    PubMed  CAS  Google Scholar 

  32. Blum K., Braverman E.R., Wood R.C., Gill J., Li C., Chen T.J., Taub M., Montgomery A.R., Sheridan P.J., Cull J.C.: Increased prevalence of the TaqI A1 allele of dopamine receptor gene (DRD2) in obesity with comorbid substance use disorder: a preliminary report. Pharmacogenetics, 6, 297–305, 1996.

    Article  PubMed  CAS  Google Scholar 

  33. Hinney A., Friedel S., Remschidt H., Hebebrand J.: Genetic risk factors in eating disorders. Am. J. Pharmacogenomics, 4, 209–223, 2004.

    Article  PubMed  CAS  Google Scholar 

  34. Kaye W.H., Bulik C.M., Thornton L., Barbarich N., Masters K.: Comorbidity of anxiety disorders with anorexia and bulimia nervosa. Am. J. Psychiatry, 161, 2215–2221, 2004.

    Article  PubMed  Google Scholar 

  35. Milos G., Spindler A., Schnyder U.: Psychiatric comorbidity and Eating Disorder Inventory (EDI) profiles in eating disorder patients. Can. J. Psychiatry, 49, 179–184, 2004.

    PubMed  Google Scholar 

  36. Devlin B., Bacanu S.A., Klump K.I., Bulik C.M., Fichter M.M., Halmi K.A., Kaplan A.S., Strober M., Treasure J., Woodside D.B., Kaye W.H.: Linkage analysis of anorexia nervosa incorporating behavioral covariates. Hum. Mol. Genetics, 11, 689–696, 2002.

    Article  CAS  Google Scholar 

  37. Bulik C.M., Klump K.L., Thornton L., Kaplan A.S., Devlin B., Fichter M.M., Halmi K.A., Strober M., Woodside D.B., Crow S., Mitchell J., Rotondo A., Mauri M., Cassano G., Keel P., Berettini W.H., Kaye W.H.: Alcohol use disorder comorbidity in eating disorders: a multicenter study. J. Clin. Psychiatry, 65, 1000–1006, 2004.

    Article  PubMed  Google Scholar 

  38. Limbert C.: The eating disorders inventory: a test of the factor structure and internal consistency in a nonclinical sample. Health Care for Women International, 25, 165–178, 2004.

    Article  PubMed  Google Scholar 

  39. Fairburn C.G., Welch S.L., Doll H.A., Davies B.A., O’Connor M.E.: Risk factors for bulimia nervosa. A community-based case-control study. Arch. Gen. Psychiatry, 54, 509–517, 1997.

    Article  PubMed  CAS  Google Scholar 

  40. Fairburn C.G., Cooper Z., Doll H.A., Welch S.L.: Risk factors for anorexia nervosa: three integrated casecontrol comparisons. Arch. Gen. Psychiatry, 56, 468–476, 1999.

    Article  PubMed  CAS  Google Scholar 

  41. Lawford B.R., Young R.McD., Noble E.P., Sargent J., Rowell J., Shadforth S., Zhang X., Ritchie T.: The D2 dopamine receptor A1 allele and opioid dependence: association with heroin use and response to methadone treatment. Am. J. Med. Genetics, (Neuropsychiatric Genetics), 96, 592–598, 2000.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. Brunani MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nisoli, E., Brunani, A., Borgomainerio, E. et al. D2 dopamine receptor (DRD2) gene Taq1A polymorphism and the eatingrelated psychological traits in eating disorders (anorexia nervosa and bulimia) and obesity. Eat Weight Disord 12, 91–96 (2007). https://doi.org/10.1007/BF03327583

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03327583

Key words

Navigation